You are here

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: August 2020 to July 2025

AbstractFullPdf
Aug 2020919126
Sep 2020299299147
Oct 202010610651
Nov 2020848248
Dec 202010210251
Jan 202116616660
Feb 2021131131382
Mar 2021144144112
Apr 202111211243
May 202115915951
Jun 202112612650
Jul 202114714769
Aug 202110910951
Sep 202111311347
Oct 202111511567
Nov 202112512488
Dec 2021939358
Jan 2022757751
Feb 2022606135
Mar 202211311470
Apr 2022899754
May 202211011358
Jun 202210310649
Jul 20229710061
Aug 202212413265
Sep 202212112237
Oct 202211516237
Nov 202212512561
Dec 202212312331
Jan 2023848627
Feb 2023989824
Mar 2023606025
Apr 2023575724
May 2023444416
Jun 2023414117
Jul 2023414123
Aug 2023404127
Sep 2023313112
Oct 2023424216
Nov 2023515331
Dec 2023565613
Jan 2024464723
Feb 2024404121
Mar 2024565842
Apr 2024505336
May 2024485135
Jun 2024353519
Jul 2024656637
Aug 2024444422
Sep 2024404121
Oct 2024353519
Nov 2024495025
Dec 2024515129
Jan 2025565623
Feb 2025495030
Mar 2025777735
Apr 2025757527
May 2025404017
Jun 2025333312
Jul 2025110
Total501251052738